US 7144862
Orally administered peptides to ameliorate atherosclerosis
granted A61KA61K38/00
Quick answer
US patent 7144862 (Orally administered peptides to ameliorate atherosclerosis) held by The Regents of the University of California expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 48
- CPC classes
- A61K, A61K38/00